DNTH

Dianthus Therapeutics Inc

NASDAQ · Biotechnology

$50.75

+4.17 (+8.95%)

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

21 analysts

Buy 20 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -23.5% upside

Low Target $27.89

Average Target $38.82

High Target $53.79

Current Price $50.75

Current
$50.75

Target
$38.82

$27.89 $38.82 avg $53.79